California firm licenses ‘potent’ anti-measles antibodies from Vanderbilt Health for development, clinical testing
Source ↗
👁 1
💬 0
Vanderbilt Health researchers and colleagues have isolated human monoclonal antibodies from previously infected individuals that potently neutralized the measles virus in the laboratory and strongly inhibited viral replication in two animal models.
California-based Saravir Biopharma Inc. has licensed the antibodies and is seeking funding for further development and clinical testing that — within 18 months to two years — could lead to the first monoclonal antibody therapy against the highly in
California-based Saravir Biopharma Inc. has licensed the antibodies and is seeking funding for further development and clinical testing that — within 18 months to two years — could lead to the first monoclonal antibody therapy against the highly in
Comments (0)